Pharmaceutical company Mundipharma on Friday confirmed that its BETADINE antiseptic products are effective against the new coronavirus (SARS-CoV-2) that triggers COVID-19 disease and the research results were published in the Infectious Disease and Therapy Journal and accepted by the British Dental Journal (BDJ) and published by Springer Nature on behalf of the British Dental Association.

Based on the laboratory tests at Duke-NUS Medical School in Singapore, the company demonstrated that BETADINE antiseptic products are effective against the new coronavirus (SARS-CoV-2) that triggers COVID-19 disease. The tests showed that the strong virucidal activity of BETADINE kills 99.99% of the SARS-CoV-2 viruses within 30 seconds. The BETADINE antiseptics contain povidone iodine (PVP-I), which acts against numerous microorganisms including bacteria, viruses and fungi and is usually used in hospitals.

The company added that BETADINE antiseptic products, i. H. Solution (10% PVP-I), skin cleanser (7.5% PVP-I), gargle and mouthwash (1.0% PVP-I) and throat spray (0.45% PVP-I) were subjected to tests. The study will be expanded by addition laboratory tests conducted at the Tropical Infectious Diseases Research and Education Center (TIDREC) at the University of Malaya, Malaysia.